可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Funder JW.The nongenomic actions of aldosterone[J].Endocr Rev,2005,26(3):313-321.
[2]Pitt B,RemmeW,Zannad F,et al.Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction[J].N Engl J Med,2003,348(14):1309-1321.
[3]Fayssoil A. Aldosterone antagonists in patients with heart failure[J].JAMA,2010,303(9):833.
[4]Takeda M,Tatsumi T,Matsunaga S,et al.Spironolactone modulates expressions of cardiac mineralocorticoid receptorand 11 betahydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in postinfarct rat hearts[J].Hypertens Res,2007,30(5):427-437.
[5]Steg PG,Dabbous OH,Feldman LJ,et al.Determinants and prognostic impact of heart failure complicating acute coronary syndromes:observations from the Global Registry of Acute Coronary Events (GRACE)[J].Circulation,2004,109(4):494-499.
[6]Pitt B.The measurement of plasma aldosterone in patients postmyocardial infarction[J].Eur Heart J,2008,29(20):2451-2452.
[7]Palmer BR,Pilbrow AP,Frampton CM,et al.Plasma aldosterone levels during hospitalization are predictive of survival postmyocardial infarction[J].Eur Heart J,2008,29(20):2489-2496.
[8]Beygui F,Collet JP,Benoliel JJ,et al.High plasma aldosterone levels on admission are associated with death in patients presenting with acute STelevation myocardial infarction[J].Circulation,2006,114(24):2604-2610.
[9]Weir RA,Tsorlalis IK,Steedman T,et al.Aldosterone and cortisol predict mediumterm left ventricular remodelling following myocardial infarction[J].Eur J Heart Fail,2011,13(12):1305-1313.
[10]Yuyun MF,Jutla SK,Quinn PA,et al.Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction[J].Heart Asia,2012,4(1):102-107.